Evidence map›Paper›PMID 35398405›Full record

ArticleThe Journal of infection2022

SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients.

Chung-Yi Cheng, Shih-Hsin Hsiao, Te-Chao Fang, Yen-Chung Lin, Jude Chu-Chun Wang, Ching-Sheng Hung, Tso-Hsiao Chen, Yuh-Mou Sue

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chung-Yi ChengDivision of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 250 Wuxing Street, Taipei 11031, Taiwan; Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, No. 111 Sec. 3, Xinlong Rd, Taipei 11696, Taiwan; Taipei Medical University Research Center of Urology and Kidney, No. 250 Wuxing St., Taipei 11031, Taiwan.
Shih-Hsin HsiaoDivision of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 250 Wuxing St., Taipei 11031, Taiwan; Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, No.252 Wuxing St., Taipei 11031, Taiwan.
Te-Chao FangDivision of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 250 Wuxing Street, Taipei 11031, Taiwan; Taipei Medical University Research Center of Urology and Kidney, No. 250 Wuxing St., Taipei 11031, Taiwan; Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital, No. 252 Wuxing Street, Taipei 11031, Taiwan.
Yen-Chung LinDivision of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 250 Wuxing Street, Taipei 11031, Taiwan; Taipei Medical University Research Center of Urology and Kidney, No. 250 Wuxing St., Taipei 11031, Taiwan; Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital, No. 252 Wuxing Street, Taipei 11031, Taiwan.
Jude Chu-Chun WangDivision of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, No.252 Wuxing St., Taipei 11031, Taiwan.
Ching-Sheng HungSchool of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan; Department of Laboratory Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan.
Tso-Hsiao ChenDivision of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 250 Wuxing Street, Taipei 11031, Taiwan; Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, No. 111 Sec. 3, Xinlong Rd, Taipei 11696, Taiwan; Taipei Medical University Research Center of Urology and Kidney, No. 250 Wuxing St., Taipei 11031, Taiwan. Electronic address: 88128@w.tmu.edu.tw.
Yuh-Mou SueDivision of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 250 Wuxing Street, Taipei 11031, Taiwan; Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, No. 111 Sec. 3, Xinlong Rd, Taipei 11696, Taiwan; Taipei Medical University Research Center of Urology and Kidney, No. 250 Wuxing St., Taipei 11031, Taiwan. Electronic address: sueym@w.tmu.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19VaccinesAntibody FormationChAdOx1 nCoV-19HumansRenal DialysisRNA, ViralSARS-CoV-2VaccinationChAdOx1 nCoV-19RNA, ViralVaccines

Identifiers

PMID35398405
PMCPMC8988583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.